Praxis recently provided recruitment services to a pharmaceutical company for a study to test a medication for a women’s health indication. This was the third successful brand extension for their client. In this latest campaign execution, specific social media tactics were included to help drive the 1365% ROI the sponsor realized. This latest recruitment program over-delivered on patients by 73% for two thirds the planned recruitment investment.
According to David Fox, President and CEO of Praxis “As we continue to support and partner with this sponsor each step builds upon the previous. Our initial brand building efforts and up-front planning pay dividends with heightened awareness among our patient population. All of this adds up to saved money and time for the sponsor."
The study was centrally managed and patient recruitment results were available in real-time, 24/7 using PraxisDirect®, Praxis’ online study management technology. PraxisDirect also played a role in the daily life of the study coordinator by offering key assistance and tracking regarding patient outcomes.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.